Startseite>>Signaling Pathways>> GPCR/G protein>> LPL Receptor>>Vibozilimod

Vibozilimod (Synonyms: SCD-044)

Katalog-Nr.GC64434

Vibozilimod (SCD-044, Beispiel 33) ist ein S1p1-Rezeptoragonist (aus Patent WO2012140020A1 entnommen).

Products are for research use only. Not for human use. We do not sell to patients.

Vibozilimod Chemische Struktur

Cas No.: 1403232-33-6

Größe Preis Lagerbestand Menge
1mg
155,00 $
Auf Lager
5mg
342,00 $
Auf Lager
10mg
549,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Vibozilimod (SCD-044, example 33) is a S1p1 receptor agonist (extracted from patent WO2012140020A1)[1].

[1]. Marc Capet, et al. Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists. Patent. WO2012140020A1.

Bewertungen

Review for Vibozilimod

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Vibozilimod

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.